≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of oropharynx

Endpoint Browser

C3_OROPHARYNX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C09, C10
  • Cause of death: ICD-9 — 146
  • Cause of death: ICD-8 — 146
  • Cancer registry: Topography ICD-O-3 — C09|C10
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

529

4. Check minimum number of events

None

529

5. Include endpoints

529

6. Filter based on genotype QC (FinnGen only)

529

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 529 162 367
Unadjusted period prevalence (%) 0.13 0.06 0.16
Median age at first event (years) 61.64 62.06 61.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
496
Matched controls
4958
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
267.7
232
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
265.1
230
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
114.2
182.2
191
27
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
181.8
163
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
114.8
169.6
178
24
130
Kela drug reimbursment
Malignant tumour
20.5
160.0
266
264
EMB10
NOMESCO Finland
Tonsillectomy
40.6
146.5
186
72
A03FA01
ATC
metoclopramide; systemic, rectal
13.2
140.7
315
578
WF002
NOMESCO Finland
Radical radiotherapy
17.0
108.5
185
167
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
573.7
98.0
94
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
281.4
93.0
92
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
23.7
86.6
127
71
EMA10
NOMESCO Finland
Biopsy of tonsil
492.4
85.8
83
*
N02AA05
ATC
oxycodone; systemic
8.4
85.2
226
450
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
442.9
78.1
76
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
20.0
76.2
118
76
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.6
74.5
137
135
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
165.2
68.9
71
5
R4190
NOMESCO Finland
Nutritional therapy
22.8
68.5
101
55
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
106.8
68.0
73
8
A04AA01
ATC
ondansetron; systemic, rectal
10.9
63.7
131
158
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
50.1
60.9
73
17
UJC01
NOMESCO Finland
Scopy of lower throat
36.6
58.5
75
24
A04AA02
ATC
granisetron; systemic, transdermal
9.6
57.1
126
170
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.7
56.1
284
1103
8070/3-C09.0
ICD-O-3
Squamous cell carcinoma, NOS, of tonsillar fossa
+∞
55.2
52
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
209.8
55.2
56
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
39.2
53.9
68
20
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
24.7
53.4
76
36
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
11.1
51.6
103
114
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
29.5
51.0
69
27
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
50.9
48
*
H02AB02
ATC
dexamethasone; systemic
6.6
49.6
143
285
ZX095
NOMESCO Finland
Combined chemoradiotherapy
54.5
49.2
58
12
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.8
48.9
94
96
ZX090
NOMESCO Finland
Other technic of radiotherapy
14.9
48.3
83
66
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
49.4
47.5
57
13
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
9.4
47.4
104
136
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
80.8
45.9
51
7
WF003
NOMESCO Finland
Adjuvant radiotherapy
11.2
41.8
82
86
UDH02
NOMESCO Finland
Rhinopharyngoscopy
8.5
41.7
97
138
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.6
40.4
293
1412
UDQ12
NOMESCO Finland
Flexible laryngoscopy
8.7
40.3
92
127
SAA03
NOMESCO Finland
Extended examination of mouth
3.6
39.6
267
1205
A07AA02
ATC
nystatin; oral
7.6
38.9
97
153
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
395.5
37.5
37
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.2
37.5
131
319
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
58.6
37.0
43
8
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
52.1
36.3
43
9
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
21.7
34.7
51
26
EBA15
NOMESCO Finland
Extraction of large number of teeth
8.0
34.0
81
118
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.6
32.9
81
124
GBB00
NOMESCO Finland
Tracheostomy
18.2
32.7
51
31
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
+∞
32.7
31
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
94.0
32.2
35
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.3
31.4
89
166
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.8
31.1
75
111
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
22.8
29.2
42
20
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
12.5
29.1
53
47
J35.1
ICD-10 Finland
Hypertrophy of tonsils
28.1
28.8
39
15
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
28.7
205
903
ENA10
NOMESCO Finland
Biopsy of pharynx
82.6
28.1
31
*
EBA10
NOMESCO Finland
Surgical removal of tooth
4.8
28.0
102
253
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.2
26.2
88
199
R13
ICD-10 Finland
Dysphagia
5.6
25.7
79
161
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.9
25.7
90
213
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
26.8
25.6
35
14
ENB20
NOMESCO Finland
Pharyngectomy
262.6
24.9
25
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.0
24.0
107
320
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
9.4
22.9
48
56
A04AD12
ATC
aprepitant; systemic
11.4
22.3
42
40
UJC02
NOMESCO Finland
Rigid oesophagoscopy
37.0
22.3
28
8
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
65.6
22.1
25
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
22.0
21
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.4
22.0
60
105
ZX070
NOMESCO Finland
Intensity modified radiotherapy
9.3
21.9
46
54
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
12.0
21.8
40
36
K11.70
ICD-10 Finland
Hypoptyalism
52.5
21.3
25
5
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
9.7
20.5
42
47
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.5
20.5
63
128
R07.0
ICD-10 Finland
Pain in throat
6.1
20.4
57
103
8070/3-C10.9
ICD-O-3
Squamous cell carcinoma, NOS, of oropharynx, NOS
+∞
19.9
19
*
JN4BD
NOMESCO Finland
Extensive body CT
3.5
19.8
102
340
H03AA01
ATC
levothyroxine sodium; systemic
2.9
19.4
136
565
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
57.4
19.1
22
*
JN6AD
NOMESCO Finland
CT of torso and neck
18.0
18.9
29
17
A06AD11
ATC
lactulose; oral
3.2
18.6
110
403
WW500
NOMESCO Finland
Blood transfusion
5.4
18.4
57
117
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.3
18.2
57
118
WX002
NOMESCO Finland
Sedation and analgesia
2.8
18.2
140
614
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
69.2
17.8
20
*
C10.3
ICD-10 Finland
Malignant neoplasm: Posterior wall of oropharynx
+∞
17.8
17
*
L03AA02
ATC
filgrastim; parenteral
7.5
17.8
42
60
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
98.6
17.7
19
*
SBB10
NOMESCO Finland
Teeth copy
5.3
17.2
54
112
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
18.2
17.1
26
15
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
4.1
17.1
69
186
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.5
17.0
166
829
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.8
16
*
WX402
NOMESCO Finland
General anaesthesia
2.8
16.5
119
496
WZC30
NOMESCO Finland
Teaching
2.9
16.3
109
433
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
16.2
268
1721
GD1AD
NOMESCO Finland
Thorax CT examination
5.1
16.1
52
112
A02BC05
ATC
esomeprazole; systemic
2.2
15.7
238
1459
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
58.5
14.9
17
*
C09
ICD-10 Finland
Malignant neoplasm of tonsil
+∞
14.7
14
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
37.3
14.5
18
5
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
17.6
14.4
22
13
T05
ICPC
Feeding problem of adult
23.1
14.3
20
9
TJD20
NOMESCO Finland
Change of gastrostomy tube
18.2
13.9
21
12
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
55.0
13.9
16
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
20.8
13.9
20
10
C09.1
ICD-10 Finland
Malignant neoplasm: Tonsillar pillar (anterior)(posterior)
+∞
13.6
13
*
C10.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oropharynx
+∞
13.6
13
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
16.8
13.6
21
13
ENB40
NOMESCO Finland
Excision of branchial cyst or fistula
143.8
13.5
14
*
EMB00
NOMESCO Finland
Excision of lesion of tonsil or adenoids
143.8
13.5
14
*
Z51.5
ICD-10 Finland
Palliative care
3.8
13.2
57
163
RD210
NOMESCO Finland
NA
11.4
13.2
24
22
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.7
13.1
26
28
K05.31
ICD-10 Finland
Periodontitis pronounced
2.9
13.0
86
338
WX110
NOMESCO Finland
Local anesthesy
2.1
12.9
345
2594
J02AC01
ATC
fluconazole; systemic
2.2
12.7
167
938
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.2
12.7
49
127
C10.0
ICD-10 Finland
Malignant neoplasm: Vallecula
+∞
12.5
12
*
Z3226
NOMESCO Finland
Physiotherapist
2.4
12.3
121
592
ZX120
NOMESCO Finland
Intravenous
3.0
12.3
75
279
RD160
NOMESCO Finland
NA
38.6
12.3
15
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.5
12.1
22
20
L03AA13
ATC
pegfilgrastim; parenteral
5.1
11.9
37
77
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
10.0
11.9
23
24
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
23.5
11.6
16
7
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.6
11.6
23
25
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
7.8
11.6
26
35
SCA03
NOMESCO Finland
Preventive oral health care, extensive
5.1
11.5
36
75
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
11.5
11
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
122.7
11.5
12
*
UDQ22
NOMESCO Finland
Microlaryngoscopy
17.6
11.3
17
10
A04AA55
ATC
palonosetron, combinations; systemic
6.3
11.2
29
48
ZXE00
NOMESCO Finland
One hour or less
2.0
11.1
210
1353
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
5.3
11.0
33
66
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
10.9
206
1323
EB1WA
NOMESCO Finland
NA
11.6
10.6
19
17
SXC03
NOMESCO Finland
Other oral or dental procedure
10.4
10.6
20
20
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
10.5
67
255
C10.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of oropharynx
+∞
10.4
10
*
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
23.9
10.3
14
6
K02.1
ICD-10 Finland
Caries of dentine
1.9
10.3
271
1945
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.7
10.1
21
25
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
15.0
10.1
16
11
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
40.9
10.0
12
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
40.9
10.0
12
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
10.0
65
251
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.5
10.0
25
40
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
9.9
162
976
XW000
NOMESCO Finland
Bone marrow biopsy
3.8
9.9
41
114
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
26.6
9.9
13
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
9.8
76
325
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
7.0
9.7
23
34
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
56.1
9.7
11
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
10.3
9.6
18
18
R4110
NOMESCO Finland
Physiotherapy
2.0
9.5
150
890
N05CF01
ATC
zopiclone; oral
1.9
9.4
166
1026
1460A
ICD-9 Finland
Malignant neoplasm of oropharynx, Tonsil
+∞
9.4
9
*
8085/3-C09.9
ICD-O-3
Squamous cell carcinoma, HPV positive of tonsil, NOS
+∞
9.4
9
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.4
9.4
27
52
PJA10
NOMESCO Finland
Exploration of lymph nodes
9.8
9.3
18
19
K05.30
ICD-10 Finland
Periodontitis complex
2.4
9.3
86
401
A02BC02
ATC
pantoprazole; systemic
1.8
9.3
327
2549
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.3
9.3
33
80
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.0
9.2
36
95
Z2446
NOMESCO Finland
Social worker
3.2
9.2
47
155
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
9.1
42
128
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.5
9.1
31
72
JN4DR
NOMESCO Finland
Whole body metabolic PET with CT
37.4
9.0
11
*
SBA00
NOMESCO Finland
Microbiological examinations
5.4
9.0
26
50
Z2221
NOMESCO Finland
Medical doctor
2.0
9.0
145
863
UDQ02
NOMESCO Finland
Direct laryngoscopy
12.8
8.9
15
12
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
8.8
111
599
J35.9
ICD-10 Finland
Chronic disease of tonsils and adenoids, unspecified
50.9
8.7
10
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
11.9
8.6
15
13
R4130
NOMESCO Finland
Speech therapy
6.2
8.5
22
37
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
91.5
8.4
9
*
UGC02
NOMESCO Finland
Rigid bronchoscopy
91.5
8.4
9
*
UJC12
NOMESCO Finland
Flexible oesophagoscopy
13.1
8.4
14
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
8.4
119
671
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
8.4
8
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.4
8.4
40
126
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
11.0
8.3
15
14
K08.3
ICD-10 Finland
Retained dental root
2.8
8.3
55
215
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.6
8.2
23
43
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.5
8.2
37
111
EBB10
NOMESCO Finland
Insertion of dental implant
7.7
8.2
18
24
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.2
8.1
24
48
SBA10
NOMESCO Finland
Measurement of excretion of saliva
12.0
8.1
14
12
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
22.4
8.0
11
5
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.5
7.9
65
284
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.9
129
767
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.2
7.9
41
137
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.0
7.9
45
160
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.7
7.9
16
19
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
5.2
7.8
23
46
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
7.8
189
1282
EBA00
NOMESCO Finland
Extraction of tooth
1.8
7.7
166
1085
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
25.4
7.6
10
*
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
25.4
7.6
10
*
EHA10
NOMESCO Finland
Biopsy of palate
10.2
7.6
14
14
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
10.2
7.6
14
14
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
7.6
60
258
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.6
7.5
52
211
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.7
7.4
20
36
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
81.2
7.4
8
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
13.6
7.4
12
9
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
13.6
7.4
12
9
EBB15
NOMESCO Finland
Insertion of dental implant abutment
9.6
7.3
14
15
J39.2
ICD-10 Finland
Other diseases of pharynx
16.0
7.3
11
7
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
7.1
81
418
WX199
NOMESCO Finland
Other local analgesia
4.1
7.1
26
66
XQ902
NOMESCO Finland
Other photography
14.0
6.9
11
8
Z3231
NOMESCO Finland
Registered nurse
1.8
6.9
145
936
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
11.1
6.8
12
11
1XC02
NOMESCO Finland
NA
11.1
6.8
12
11
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.7
6.8
28
79
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.9
6.8
117
706
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
17.0
6.8
10
6
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
17.0
6.8
10
6
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
17.0
6.8
10
6
R50.9
ICD-10 Finland
Fever, unspecified
2.1
6.7
74
375
J01CE02
ATC
phenoxymethylpenicillin; oral
1.7
6.7
320
2593
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
22.9
6.7
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.6
6.7
16
25
XX3ZW
NOMESCO Finland
NA
70.7
6.4
7
*
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
70.7
6.4
7
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
6.4
132
842
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
6.4
65
317
K11.2
ICD-10 Finland
Sialoadenitis
4.0
6.4
24
63
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
18.3
6.3
9
5
J01DB01
ATC
cefalexin; oral
1.8
6.3
396
3439
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
6.3
6
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
+∞
6.3
6
*
8070/3-C10.3
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of oropharynx
+∞
6.3
6
*
QA9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head or neck, unspecified
+∞
6.3
6
*
9691/3-C09.9
ICD-O-3
Follicular lymphoma, grade 2 of tonsil, NOS
+∞
6.3
6
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
6.3
6
*
8083/3-C09.9
ICD-O-3
Basaloid squamous cell carcinoma of tonsil, NOS
+∞
6.3
6
*
8072/3-C09.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of tonsil, NOS
+∞
6.3
6
*
A01AB09
ATC
miconazole; local oral
2.5
6.2
45
187
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
7.8
6.2
13
17
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.2
6.1
11
11
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
6.1
37
140
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
5.7
6.0
16
29
M04AA01
ATC
allopurinol; systemic
2.0
6.0
81
448

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
244
417
10.00
152.37
1.5
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
99
111
10.74
83.24
1.3
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
106
131
9.87
82.85
3.6
3.0
mg/l
1.1
1.6
7.94
106
119
(3012095) Magnesium [Moles/volume] in Serum or Plasma
252
771
5.33
79.67
7.9
3.6
mmol/l
0.8
0.8
11.33
245
727
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
159
474
4.37
48.74
3.0
2.3
g/l
0.2
0.2
6.68
154
435
(40768804) Tissue Pathology biopsy report
335
1685
3.69
46.61
2.4
2.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
41
30
14.73
44.67
1.2
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
400
2516
3.42
33.82
15.2
9.8
e9/l
4.0
4.2
0.48
372
2218
(3015377) Calcium [Moles/volume] in Serum or Plasma
281
1478
2.92
32.31
6.4
3.6
mmol/l
2.4
2.3
2.99
266
1289
(40768795) Lymph node Pathology biopsy report
40
47
9.13
31.77
1.1
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
364
2423
2.61
23.05
10.0
7.0
umol/l
10.2
12.3
6.02
359
2302
(40758558) Short blood count panel - Blood
211
1110
2.50
22.13
11.7
7.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
316
1997
2.45
21.97
6.6
5.3
g/l
35.1
35.2
0.06
301
1856
(3026389) Candida sp identified in Specimen by Organism specific culture
29
38
8.02
21.01
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
250
1493
2.28
18.90
6.2
6.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
315
2109
2.22
17.51
4.7
4.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
301
2008
2.16
16.51
7.3
6.1
%
0.7
0.7
0.16
285
1885
(3006504) Eosinophils/100 leukocytes in Blood
305
2055
2.14
16.18
7.4
6.2
%
2.8
2.9
0.24
290
1921
(3021879) Hepatitis B virus core Ab [Presence] in Serum
74
265
3.08
16.02
1.3
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
304
2067
2.11
15.48
7.7
6.5
%
9.5
9.0
1.46
290
1943
(3001604) Monocytes [#/volume] in Blood
315
2176
2.11
15.31
7.1
6.0
e9/l
0.6
0.6
0.06
284
1888
(3006315) Basophils [#/volume] in Blood
315
2188
2.09
14.94
7.2
6.0
e9/l
0.0
0.0
0.44
284
1907
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
158
845
2.24
14.93
5.1
3.4
mmol/l
2.5
2.5
2.27
149
745
(3002030) Lymphocytes/100 leukocytes in Blood
306
2104
2.08
14.90
7.6
6.3
%
23.9
26.9
4.06
289
1969
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
437
3465
2.50
14.67
12.3
8.4
u/l
80.1
80.1
0.00
424
3251
(3019198) Lymphocytes [#/volume] in Blood
317
2221
2.07
14.51
7.4
6.1
e9/l
1.7
2.1
1.58
287
1976
(3032080) INR in Blood by Coagulation assay
293
1996
2.05
14.48
8.4
9.9
inr
1.2
1.3
0.49
88
573
(3013115) Eosinophils [#/volume] in Blood
320
2253
2.06
14.41
7.6
6.2
e9/l
0.2
0.2
1.41
288
2000
(3018010) Neutrophils/100 leukocytes in Blood
300
2073
2.03
14.12
7.4
6.1
%
59.9
57.7
2.29
284
1949
(3044640) Blood type and Crossmatch panel - Blood
230
1463
2.01
13.49
3.1
2.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
121
624
2.22
12.23
5.5
6.3
mmol/l
1.0
1.0
1.03
111
582
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
312
2258
1.93
12.06
8.4
7.2
mmol/l
1.2
1.2
0.18
261
1922
(3023368) Bacteria identified in Blood by Culture
214
1378
1.93
11.70
5.6
4.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
34
91
3.92
11.48
1.5
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
105
534
2.21
10.89
1.4
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
12
10.21
10.47
1.5
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
111
588
2.12
10.34
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
187
1190
1.88
10.32
1.4
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
39
124
3.32
10.22
1.4
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
284
2071
1.80
9.95
7.5
6.4
mmol/l
1.2
1.2
0.09
265
1878
(21494814) CD8 cells/100 lymphocytes in Specimen
12
13
9.42
9.90
1.5
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
105
560
2.09
9.56
2.1
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
38
124
3.22
9.56
1.4
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
268
1950
1.76
9.20
11.8
10.5
e9/l
0.0
0.0
0.49
237
1622
(3017143) Hepatitis C virus Ab [Presence] in Serum
85
426
2.19
9.06
1.3
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
88
449
2.15
8.96
1.3
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
350
2762
1.79
8.94
6.1
5.2
mmol/l
6.4
6.8
3.38
333
2596
(46235355) HIV 1 and 2 tests - Meaningful Use set
98
533
2.03
8.40
1.4
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
207
2.56
8.18
1.2
1.2
iu/ml
77.7
133.3
0.62
13
76
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
171
1123
1.77
8.17
2.7
2.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
26
74
3.64
8.07
1.5
1.7
—
—
—
0
0
(44790049)
23
61
3.90
7.88
1.5
1.7
—
—
—
0
0
(44790048)
23
61
3.90
7.88
1.5
1.7
—
—
—
0
0
(44806118)
23
61
3.90
7.88
1.5
1.7
—
—
—
0
0
(44790047)
23
61
3.90
7.88
1.5
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
331
2.21
7.76
1.7
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
54
4.01
7.50
1.3
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
50
4.12
7.41
1.5
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
26
5.50
7.28
1.8
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
91
3.19
7.12
1.4
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
76
400
2.05
7.09
9.2
9.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
374
3102
1.70
7.05
5.2
3.5
pmol/l
14.6
14.9
1.85
348
2772
(40765096) Chromosome analysis panel by Banding
12
20
6.12
6.93
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
100
587
1.87
6.78
1.6
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
15
33
4.65
6.49
1.7
1.7
—
32.4
—
0
5
(3011412) CD3 cells [#/volume] in Blood
17
42
4.15
6.40
1.9
2.0
e9/l
1.4
1.0
0.55
12
22
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
23
71
3.34
6.35
1.3
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
187
1331
1.63
6.32
5.2
4.3
ph
7.4
7.4
0.03
47
268
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
26
5.10
6.25
1.8
2.0
—
18.3
—
0
12
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
128
2.68
6.17
1.6
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
40
4.09
5.93
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
73
409
1.91
5.68
5.3
4.6
%
1.2
0.7
0.65
32
141
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
91
547
1.80
5.68
3.3
3.1
umol/l
5.9
9.5
2.85
85
494
(3045142) Bone marrow Pathology biopsy report
21
66
3.27
5.65
1.3
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
17
5.98
5.64
4.3
2.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
78
3.04
5.48
1.4
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
71
399
1.90
5.47
3.5
2.1
nmol/l
406.0
359.3
1.10
65
366
(3021440) Promyelocytes/100 leukocytes in Blood
68
380
1.91
5.33
5.3
4.8
%
0.1
0.1
0.15
30
128
(40760892) CBC W Ordered Manual Differential panel - Blood
137
938
1.62
5.28
7.2
4.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
81
2.92
5.15
1.3
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
19
5.35
5.06
3.2
3.1
u/l
178.3
208.8
—
10
19
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
475
4341
1.92
5.02
25.3
16.0
mg/l
25.9
26.5
0.13
438
3481
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
32
4.14
4.92
4.0
3.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
63
3.09
4.72
1.5
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
34
3.89
4.56
1.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
62
355
1.85
4.52
2.3
3.0
ml/min/173m2
61.3
62.4
0.09
20
148
(3002179) Metamyelocytes/100 leukocytes in Blood
63
363
1.83
4.50
4.7
4.5
%
0.6
0.3
0.92
19
101
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
94
2.63
4.44
1.9
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
60
3.07
4.44
1.6
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
65
381
1.80
4.40
4.6
4.2
mmol/l
1.3
1.2
1.08
60
341
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
83
524
1.69
4.34
2.0
2.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
40
201
2.07
4.25
3.0
3.5
pmol/l
4.2
4.6
1.58
35
176
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
400
4376
0.65
4.21
4.1
4.7
mmol/l
1.4
1.4
0.98
358
4009
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
27
4.14
4.18
1.2
2.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
27
4.14
4.18
1.2
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
61
357
1.80
4.15
5.5
4.8
%
0.0
0.1
0.74
23
110
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
23
4.41
4.10
1.5
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
402
3572
1.52
4.09
29.9
19.4
%
13.9
13.8
1.35
397
3504
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
108
748
1.56
3.88
2.1
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
168
1277
1.46
3.86
4.2
2.8
umol/l
2818.8
7880.7
1.05
149
1097
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
80
518
1.64
3.80
1.9
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
387
4240
0.67
3.74
3.8
4.3
mmol/l
1.3
1.3
0.37
345
3876
(3027945) Reticulocytes/100 erythrocytes in Blood
85
561
1.61
3.74
3.8
2.8
%
1.7
1.8
0.50
75
510
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
49
284
1.80
3.46
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
89
2.42
3.36
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
89
2.42
3.36
1.1
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
385
4197
0.70
3.27
5.1
6.3
mmol/mol
39.0
40.5
2.75
359
3875
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
84
2.44
3.26
4.5
3.2
%
60.0
55.9
0.58
20
84
(3020682) Albumin/Creatinine [Ratio] in Urine
119
1572
0.69
3.23
3.0
4.0
mg/mmol
7.7
8.7
0.15
71
1018
(3013707) Erythrocyte sedimentation rate by Westergren method
364
3234
1.40
3.20
4.8
4.1
mm/h
15.3
12.5
2.32
335
2961
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
124
2.15
3.19
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
11
6.43
3.19
1.9
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
20
4.56
3.12
1.1
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
50
2.85
3.11
1.6
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
50
2.85
3.11
1.6
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
50
2.85
3.11
1.6
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
74
2.48
3.08
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
34
3.28
3.07
1.2
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
113
2.18
3.05
6.8
6.8
iu/ml
594.6
140.7
—
5
18
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
106
772
1.47
2.97
3.0
3.1
e6/l
1.6
1.2
0.38
62
453
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
410
4402
0.70
2.94
4.2
4.8
mmol/l
4.7
4.5
2.51
374
4057
(3012516) Albumin [Mass/volume] in Urine
113
1483
0.70
2.91
2.8
3.2
mg/l
607.4
183.7
0.33
69
984
(3019550) Sodium [Moles/volume] in Serum or Plasma
487
4608
1.72
2.89
26.9
18.5
mmol/l
138.9
139.7
5.64
477
4495
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
119
891
1.43
2.88
3.7
3.9
ng/l
655.6
414.1
0.20
99
738
(3025941) Bacteria identified in Stool by Culture
40
233
1.78
2.81
1.4
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
118
1526
0.71
2.77
2.4
3.1
mmol/l
8.4
8.1
0.20
93
1270
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
14
54
2.64
2.72
3.8
2.7
nmol/l
3.0
6.0
0.49
14
54
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
37
3.01
2.70
1.2
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
73
503
1.52
2.68
4.0
3.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
57
371
1.60
2.67
3.5
2.8
g/l
9.0
10.8
2.53
51
335
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
80
2.29
2.63
4.2
2.8
e9/l
5.1
4.4
0.23
18
80
(3023103) Potassium [Moles/volume] in Serum or Plasma
487
4625
1.67
2.62
27.2
18.6
mmol/l
4.0
4.0
3.24
477
4508
(3002032) Base excess in Venous blood by calculation
64
431
1.55
2.60
3.3
3.6
mmol/l
3.3
2.1
1.59
55
341
(3044889) 12 lead EKG panel
361
3251
1.35
2.60
4.1
4.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
422
4488
0.70
2.56
4.6
5.3
mmol/l
2.8
2.7
1.44
378
4107
(3042631) Mycobacterium sp identified in Specimen
17
75
2.31
2.53
2.2
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
448
4188
1.46
2.50
23.2
14.6
ml/min/173m2
82.0
78.8
3.32
403
3496
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
82
588
1.47
2.49
10.0
8.3
kpa
5.2
5.1
0.39
77
559
(3027801) Oxygen [Partial pressure] in Arterial blood
82
589
1.46
2.47
10.0
8.3
kpa
12.6
11.9
0.68
77
564
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
96
2.13
2.46
1.2
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
421
3898
1.39
2.43
25.8
16.6
%
38.4
40.1
3.20
307
2672
(3003396) Base excess in Arterial blood by calculation
81
584
1.46
2.39
10.2
8.4
mmol/l
1.6
1.1
0.72
70
463
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
199
1.76
2.38
2.0
3.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
8
6.30
2.37
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
277
1.64
2.37
12.6
11.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
75
537
1.46
2.30
10.3
8.6
%
95.5
95.3
0.09
70
516
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
62
429
1.50
2.25
3.2
2.6
u/l
27.9
45.7
1.01
52
368
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
420
3904
1.37
2.23
6.0
4.3
mu/l
2.7
2.3
0.67
393
3517
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
54
2.44
2.21
2.8
2.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
56
0.00
2.07
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
56
0.00
2.07
0.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
106
825
1.36
2.02
3.0
2.8
e6/l
0.9
1.0
0.12
62
501
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
7
21
3.36
1.97
3.3
4.0
nmol/l
116.3
77.3
—
7
21
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
120
1.87
1.95
1.2
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
175
1469
1.29
1.95
4.2
3.6
u/l
89.8
34.0
0.51
168
1399
(3026782) Osmolality of Urine
119
949
1.33
1.93
3.2
2.8
mosm/kgh2o
541.7
572.6
0.76
100
815
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
120
1476
0.76
1.92
3.0
3.1
ug/l
0.6
0.7
1.13
81
981
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
121
1.85
1.91
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
122
1.84
1.87
1.2
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
317
2874
1.26
1.81
4.3
4.2
e6/l
224.3
2689.0
—
6
47
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
38
250
1.56
1.76
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
18
3.36
1.75
1.2
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
86
665
1.35
1.72
2.0
2.4
%
22.6
23.9
0.25
75
580
(3042936) Bacteria identified in Isolate by Culture
96
755
1.33
1.72
2.2
2.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
223
2513
0.81
1.67
4.1
5.0
ug/l
2.0
2.4
0.72
189
2249
(3006462) Nitrate [Presence] in Urine
6
19
3.18
1.66
2.3
3.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
174
2013
0.80
1.66
3.8
4.3
%
21.0
20.7
0.07
75
959
(4034850)
6
149
0.40
1.66
7.5
11.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
61
449
1.41
1.65
4.7
8.0
mmol/l
7.0
10.0
5.31
56
424
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
136
1.72
1.61
1.3
1.6
ug/g
212.4
277.7
—
10
81
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
44
616
0.69
1.59
4.2
4.7
%
31.5
31.1
0.09
34
424
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
26
2.71
1.58
3.6
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
20
3.02
1.58
1.8
14.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
143
0.41
1.54
1.2
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
15
3.35
1.52
3.0
1.5
ug/l
48.7
63.0
—
5
15
(4211845)
6
21
2.88
1.51
2.2
3.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
132
1108
1.25
1.44
2.1
2.0
mg/l
2.6
3.1
1.63
110
955
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
31
454
0.66
1.42
1.5
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
484
4676
1.41
1.42
15.6
11.3
u/l
26.2
28.0
1.70
470
4505
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
18
299
0.59
1.42
1.9
2.6
—
12.2
—
0
11
(3004789) Transferrin [Mass/volume] in Serum or Plasma
87
695
1.30
1.40
1.9
2.4
g/l
2.3
2.3
0.13
81
645
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
74
1.92
1.40
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
382
3585
1.24
1.39
30.4
20.2
g/l
332.6
333.3
0.80
374
3564
(3006653) Thiamine [Moles/volume] in Blood
6
23
2.63
1.37
1.3
1.2
nmol/l
98.0
140.5
—
6
23
(3023520) Reticulocytes [#/volume] in Blood
56
424
1.36
1.31
4.8
2.9
e9/l
69.4
70.6
0.09
49
337
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
187
1645
1.21
1.30
2.2
2.2
nmol/l
79.2
76.7
0.47
171
1439
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
18
2.79
1.28
2.8
5.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
18
2.79
1.28
1.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
215
0.55
1.26
1.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
58
447
1.33
1.22
3.9
4.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
37
2.18
1.22
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
71
1.85
1.20
1.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.3
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.3
2.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
31
215
1.47
1.19
5.4
5.9
%
1.6
1.6
0.14
26
201
(36304419) Bacteria [Presence] in Urine
146
1266
1.21
1.17
3.5
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
153
1333
1.21
1.16
3.6
3.2
e6/l
0.2
0.5
2.21
118
1027
(40768441) Liver Pathology biopsy report
0
34
0.00
1.16
0.0
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
270
0.62
1.15
1.1
1.4
—
54.9
—
0
16
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
185
1643
1.19
1.14
4.1
3.8
e6/l
85.3
107.1
0.20
134
1222
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
30
2.35
1.12
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
39
286
1.39
1.12
1.1
1.2
—
—
—
0
0
(4281824)
8
40
2.02
1.12
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
96
1.69
1.11
1.1
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
21
136
1.57
1.10
1.5
2.3
%
80.6
86.6
0.49
21
129
(3019060) Gas panel - Arterial blood
44
331
1.36
1.09
4.7
5.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
41
1.97
1.09
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
164
1447
1.19
1.08
3.7
3.3
e6/l
84.8
116.5
0.16
131
1142
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
59
1.88
1.08
5.8
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
31
220
1.43
1.07
2.5
2.2
g/l
1.3
1.5
0.79
25
189
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
316
1.36
1.05
2.8
3.8
ng/l
84.9
84.0
0.02
36
276
(3024928) Oxygen saturation in Venous blood
16
98
1.65
1.04
1.3
2.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
46
1.97
1.04
2.7
1.3
nmol/l
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
361
1.33
1.03
4.0
3.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
90
752
1.24
1.03
2.2
2.4
umol/l
12.0
13.2
0.90
81
696
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
48
1.89
1.01
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
116
998
1.21
1.00
3.2
3.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
61
1.82
0.99
1.2
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.0
—
5.5
—
0
11
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
50
1.81
0.97
2.2
2.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
174
1.46
0.97
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
32
0.00
0.95
0.0
2.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.0
—
1.1
—
0
7
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
51
1.78
0.95
2.7
1.3
nmol/l
0.5
0.6
—
9
45
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
80
951
0.81
0.94
1.5
1.7
pmol/l
460.5
5063708.5
0.50
62
790
(40761511) CBC panel - Blood by Automated count
468
4543
1.26
0.94
20.2
15.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
27
2.24
0.93
1.3
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
151
1.48
0.92
1.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.91
1.3
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.91
1.3
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.91
1.3
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.91
1.3
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
43
333
1.32
0.91
3.7
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
320
3011
1.16
0.91
4.3
4.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
101
0.49
0.90
1.2
1.2
u/l
37.6
49.1
—
5
86
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
204
1868
1.15
0.83
2.0
2.0
pmol/l
95.1
93.4
0.21
98
1008
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
46
1.75
0.83
2.9
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
32
1.88
0.82
2.7
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
480
4687
1.26
0.80
29.3
18.7
umol/l
79.3
82.4
2.08
480
4687
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.7
—
1.1
—
0
21
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
64
533
1.23
0.78
3.3
4.5
ug/l
33.0
38.1
0.06
51
442
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
112
1267
0.85
0.78
1.6
1.7
mmol/l
1.4
1.4
0.10
99
1060
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
324
0.73
0.77
1.5
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
99
1.53
0.76
2.2
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
59
1.71
0.76
1.0
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
18
124
1.47
0.76
1.7
2.5
%
196.9
206.0
0.15
18
118
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
75
1.61
0.75
1.3
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
24
2.09
0.74
1.4
1.3
u/l
33.9
42.3
—
5
18
(4027681)
5
25
2.01
0.73
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
68
1.63
0.72
4.3
4.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
186
1.36
0.71
1.1
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
83
951
0.85
0.68
4.1
3.7
kg/l
1.0
1.0
0.10
11
135
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
94
1.50
0.67
1.1
1.1
u/ml
377.5
318.0
—
8
49
(1761868) Lipid panel - Serum or Plasma
142
1561
0.88
0.66
2.7
3.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
303
2880
1.12
0.64
3.5
3.4
u/l
60.7
57.1
0.22
286
2666
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
29
1.73
0.64
1.2
2.2
u/ml
698.6
1844.0
—
5
29
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
72
830
0.85
0.64
1.2
1.2
u/ml
0.7
1.4
1.74
12
225
(3047181) Lactate [Moles/volume] in Blood
20
147
1.37
0.62
7.2
7.7
mmol/l
1.0
1.3
1.38
15
127
(3036670) Protein [Mass/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.1
—
35.7
—
0
12
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
7.2
—
0
8
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
291
1.25
0.60
1.8
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
187
1735
1.12
0.60
3.6
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
52
1.55
0.59
1.1
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
11
72
1.54
0.59
1.3
1.5
g/l
37.0
31.5
0.81
11
61
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
150
0.66
0.59
1.1
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
256
1.27
0.58
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
54
1.49
0.57
5.5
3.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
406
0.80
0.57
3.3
3.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
36
1.67
0.57
1.7
1.8
%
10.5
11.4
—
6
36
(3024731) MCV [Entitic volume]
490
4821
1.22
0.55
34.5
23.0
fl
92.0
91.4
1.72
483
4744
(3007461) Platelets [#/volume] in Blood
490
4821
1.22
0.55
34.5
23.1
e9/l
244.4
240.3
0.57
479
4690
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
565
0.83
0.55
10.9
7.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
82
1.47
0.54
1.4
2.1
%
68.0
64.2
0.20
12
82
(3035941) MCH [Entitic mass]
490
4822
1.22
0.54
34.4
23.0
pg
30.6
30.5
0.49
483
4744
(3022621) pH of Urine by Test strip
35
286
1.24
0.54
2.3
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
326
0.79
0.53
1.3
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
490
4823
1.22
0.53
34.6
23.1
e12/l
4.3
4.5
16.37
478
4678
(3010813) Leukocytes [#/volume] in Blood
490
4823
1.22
0.53
34.7
23.1
e9/l
6.6
6.8
0.75
478
4681
(3004119) Hemoglobin [Mass/volume] in Venous blood
36
296
1.23
0.53
3.3
3.1
g/l
130.1
128.4
0.19
36
291
(3013512) EKG study
156
1444
1.11
0.52
4.7
4.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
490
4825
1.21
0.51
34.7
23.2
g/l
130.1
137.4
18.54
483
4748
(3051651) Icteric interference index of Serum or Plasma
6
40
1.51
0.51
6.2
4.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
41
1.47
0.50
1.5
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
105
1154
0.89
0.49
4.5
3.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
45
1.56
0.49
1.1
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
48
1.46
0.47
1.6
2.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
40
338
1.20
0.47
1.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
129
1.33
0.46
2.9
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
129
1.33
0.46
3.4
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
117
0.68
0.46
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
81
0.61
0.46
1.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
165
1.28
0.45
1.3
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
50
1.41
0.45
1.1
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
18
139
1.31
0.44
1.6
2.8
g/l
3.6
3.8
0.25
18
132
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
113
1.34
0.43
2.4
2.5
g/l
111.2
128.8
—
10
84
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
92
0.65
0.42
1.7
3.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
32
1.57
0.42
3.2
2.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
15
0.00
0.41
0.0
1.1
—
14.6
—
0
9
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
7.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
155
1651
0.91
0.41
4.4
3.7
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
4.2
—
0
6
(3035880) pH of Pleural fluid
5
34
1.47
0.40
1.4
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
60
1.34
0.40
1.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
14
106
1.33
0.39
1.5
1.2
u/ml
1.9
2.9
—
5
17
(3015171) Extractable nuclear Ab [Units/volume] in Serum
18
142
1.28
0.39
1.4
1.2
—
2.3
—
0
12
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
170
1.25
0.37
2.7
2.4
u/ml
0.4
0.3
0.74
14
96
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
115
0.69
0.37
1.8
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
70
1.29
0.37
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
43
1.40
0.35
1.5
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
166
0.78
0.33
1.3
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
45
399
1.14
0.32
2.8
2.9
ng/l
236.7
206.7
0.21
38
358
(3000850) Epithelial cells [#/volume] in Urine
107
998
1.09
0.32
3.0
2.6
e6/l
3.6
3.9
0.14
92
882
(3019309) Folate [Moles/volume] in Red Blood Cells
92
854
1.09
0.30
1.8
1.7
nmol/l
1151.6
1187.9
0.12
63
660
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
54
1.30
0.30
1.0
1.1
%
124.6
108.8
—
7
49
(3000330) Specific gravity of Urine by Test strip
28
241
1.17
0.29
4.9
3.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
59
647
0.90
0.29
1.2
1.3
u/ml
15.4
15.1
0.01
16
249
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
173
0.80
0.29
1.2
1.8
nmol/l
59.4
40.0
1.12
14
166
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
135
1424
0.93
0.28
3.5
3.1
ng/l
1641.8
1255.6
0.49
118
1222
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
186
1.19
0.28
2.1
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
237
0.84
0.28
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
85
1.30
0.28
1.5
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
191
0.83
0.25
6.4
2.0
g/l
3.1
3.8
—
10
137
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
191
0.83
0.25
6.4
2.0
g/l
6.1
7.3
2.09
11
145
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
191
0.83
0.25
6.4
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
63
681
0.91
0.24
1.3
1.3
iu/ml
25.5
41.0
0.69
22
218
(3007164) IgA [Mass/volume] in Serum or Plasma
83
777
1.08
0.24
2.0
1.4
g/l
2.4
2.8
1.03
48
471
(3045424) Erythrocytes [Presence] in Urine
6
85
0.70
0.24
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
93
0.75
0.22
1.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
79
1.27
0.22
1.1
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
116
1.21
0.22
1.1
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
144
1.19
0.22
5.2
3.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
220
1.14
0.21
2.3
2.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
128
1223
1.06
0.21
3.5
3.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
0.5
—
0
6
(3050129) First trimester maternal screen panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
15.5
—
0
11
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
11
0.00
0.21
0.0
3.6
—
7105.6
—
0
11
(4133840)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
7.7
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.2
—
6.2
—
0
13
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
0.8
—
0
7
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
13
0.00
0.21
0.0
2.2
—
9.9
—
0
8
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
117
1.20
0.20
1.4
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
14
0.00
0.20
0.0
5.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
112
0.80
0.20
3.7
4.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
53
491
1.09
0.20
1.9
2.3
nmol/l
15.1
13.4
0.94
46
443
(21494890) Protein electrophoresis panel - 24 hour Urine
6
52
1.16
0.19
3.0
2.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
53
1.13
0.18
1.0
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
33
300
1.11
0.18
2.0
2.8
e9/l
4.4
4.1
0.20
26
234
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
152
1469
1.05
0.17
3.2
2.7
u/l
52.6
58.9
1.28
141
1367
(40760888) Immunoglobulin light chains.free panel - Serum
15
129
1.17
0.17
4.2
4.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
26
234
1.12
0.17
4.2
3.3
mmol/l
26.9
25.1
1.18
26
229
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
537
1.07
0.15
1.6
1.9
%
1.7
1.6
0.19
48
455
(1002224) Polysomnography panel
15
171
0.87
0.15
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
97
933
1.05
0.14
1.7
1.7
mg/l
1.5
1.3
0.19
79
721
(3009261) Glucose [Presence] in Urine by Test strip
219
2145
1.04
0.13
4.1
3.5
estimate
0.0
0.0
0.00
44
380
(40768797) Stomach Pathology biopsy report
64
609
1.06
0.13
1.2
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
24
219
1.10
0.13
2.2
2.4
%
0.7
0.7
0.03
24
214
(3021960) Folate [Moles/volume] in Serum or Plasma
113
1094
1.04
0.12
1.6
1.6
nmol/l
22.6
20.1
0.88
99
920
(1761482) Bacteria [#/volume] in Urine by Culture
15
133
1.13
0.12
6.5
4.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
175
1711
1.03
0.12
2.7
2.7
ug/l
231.8
172.7
1.25
159
1557
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
172
1.11
0.11
1.8
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
216
2121
1.03
0.11
5.4
4.7
estimate
0.0
0.0
0.00
45
407
(3020891) Body temperature
18
198
0.91
0.11
3.8
4.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
438
4350
1.04
0.10
4.5
4.9
mmol/l
5.9
6.1
2.43
408
3948
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
42
443
0.94
0.10
2.5
2.6
ug/l
7.8
8.4
0.09
34
393
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
146
1427
1.03
0.10
2.5
2.2
u/l
136.7
272.0
1.68
140
1344
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
87
1.15
0.09
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
134
0.89
0.09
1.8
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.5
1.9
—
—
—
0
0
(4094501)
14
127
1.11
0.08
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
75
1.07
0.07
1.0
1.1
g/l
1.5
1.6
—
8
66
(3000764) Benzodiazepines [Presence] in Urine
8
76
1.05
0.07
2.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
77
1.04
0.07
2.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
81
0.86
0.07
3.1
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
118
1.10
0.07
2.2
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
214
0.93
0.07
1.5
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
237
2344
1.02
0.06
2.7
2.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
63
649
0.97
0.06
27.8
24.9
inr
1.3
1.3
—
6
84
(40767503) Oxygen content in Capillary blood by calculation
12
109
1.10
0.06
2.9
2.8
%
14.6
15.8
—
6
60
(3048689) Calprotectin [Mass/mass] in Stool
42
435
0.96
0.05
1.5
2.4
ug/g
107.5
127.9
0.40
31
356
(3045414) Leukocytes [Presence] in Urine
21
198
1.06
0.05
2.0
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
184
1859
0.98
0.04
4.3
3.9
ng/l
29.5
45.0
1.27
150
1402
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
18
170
1.06
0.04
1.8
1.6
—
128.6
—
0
7
(3028626) Oxygen [Partial pressure] in Capillary blood
11
119
0.92
0.04
3.5
2.6
kpa
7.1
7.9
1.01
11
105
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
151
1.06
0.03
1.6
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
169
0.95
0.03
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
241
1.04
0.02
2.8
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
214
2127
1.01
0.02
4.0
3.5
estimate
0.0
0.0
0.00
45
392
(4010399)
33
338
0.97
0.01
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
24
247
0.97
0.01
4.3
3.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
104
1.06
0.01
1.2
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
106
1.04
0.00
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
117
1.03
0.00
1.1
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
98
1.02
0.00
1.6
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
98
1.02
0.00
1.1
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
102
0.98
0.00
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
26
263
0.99
0.00
3.4
2.9
e6/l
0.1
0.2
0.26
26
255
(3022145) Colonoscopy Study observation
52
516
1.01
0.00
1.4
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
55
554
0.99
0.00
1.5
1.3
titre
455.2
473.9
0.05
21
131
(3037121) Protein [Mass/volume] in Urine
18
182
0.99
0.00
6.3
3.4
g/l
0.1
0.2
—
9
82
(3021901) Oxygen saturation in Capillary blood
10
99
1.01
0.00
3.7
2.6
—
—
—
0
0
(3000492) Spirometry study
43
431
1.00
0.00
1.5
1.5
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
9
0.00
0.00
0.0
2.3
—
140.7
—
0
9
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
6.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
19.6
—
0
9
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
6.9
—
6.8
—
0
7
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
118
1180
1.00
0.00
4.3
3.7
estimate
0.0
0.0
0.50
41
380
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
79
1.01
0.00
2.3
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.8
—
0
6
(4146454)
6
63
0.95
0.00
1.8
2.8
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
51
0.98
0.00
3.4
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
76
0.92
0.00
1.0
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.8
—
0.4
—
0
5
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
2.0
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
68
0.88
0.00
1.8
1.9
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
87.7
—
0
7
(40768793) Breast Pathology biopsy report
7
72
0.97
0.00
1.4
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
14.5
—
0
5
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
63
0.95
0.00
1.8
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
54
0.93
0.00
1.0
1.2
mmol/l
8.1
7.4
—
5
35
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
58
0.86
0.00
1.8
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
52
0.96
0.00
1.4
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4306422)
6
61
0.98
0.00
1.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
98.2
—
0
5
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
79
1.01
0.00
2.3
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
5.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
140
1.00
0.00
2.0
2.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
75
0.93
0.00
2.4
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
8.7
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_OROPHARYNX – Malignant neoplasm of oropharynx

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).